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Abstract
Background: Evidence regarding the association of variation within ADRB2, the gene encoding the beta-adrenergic receptor
2 (ADRB2) with obesity and hypertension is exceedingly ambiguous. Despite negative reports, functional impacts of
individual genetic variants have been reported. Also, functional haplotypes as well as haplotype combinations affecting
expression levels in vivo of ADRB2 mRNA and protein as well as receptor sensitivity have been reported. The aim of the
present study was therefore to evaluate if variations within ADRB2 as haplotypes or as haplotype combinations confer an
increased prevalence of obesity and hypertension among adults.
Methodology/Principal Findings: We genotyped five variants required to capture common variation in a region including
the ADRB2 locus in a population-based study of 6,514 unrelated, middle-aged Danes. Phases of the genotypes were
estimated in silico. The variations were then investigated for their combined association with obesity, hypertension and
related quantitative traits. The present study did not find consistent evidence for an association of ADRB2 variants with
either obesity or hypertension when variations were analysed in a case-control study. The same lack of impact was also seen
in the quantitative trait analyses, apart from nominal differences on waist-to-hip ratio and systolic blood pressure between
specific haplotype combinations.
Conclusions/Significance: In a population-based sample of 6,514 Danes we found no consistent associations between five
common variants which tag the ADRB2 locus and prevalence of obesity or hypertension neither when analysed as individual
haplotypes nor as haplotype pairs.
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Introduction
The beta-adrenergic receptor 2 (ADRB2) is part of the
sympathetic nervous system influencing metabolic as well
cardiovascular functions. Due to this biological function, ADRB2
has been a candidate for the development of obesity and
hypertension; however, no consistent associations with these
conditions have been observed. Previous studies have especially
examined two functional variants, the Arg16Glu and the
Gln27Glu, which in few studies were associated with both obesity
[1,2] and hypertension [1,2]. However, overall there is ambiguity
regarding the effect of these variants and in our previous study
none of them were associated with either trait [3].
In addition to functional single variations, functional haplotypes
have also been reported within this locus. One study identified that
two common haplotypes, composed of 13 single nucleotide
polymorphisms (SNPs) located within the ADRB2 locus, displayed
a significantly different expression of both mRNA and protein in
HEK cells [4]. Furthermore, the response to inhalation of the
ADRB2 agonist albuterol was different depending on the
combinations of these common haplotypes [4]. Haplotypes based
on 10 of these SNPs have also showed significantly lower sensitivity
as well as a lipolytic effect in response to noradrenalin stimulation
[5]. In addition, a study identified that only four of the 13 SNPs
included in the study by Drysdale and colleagues accounted for the
majority of the haplotypic differences [6]. Also, haplotypes
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case-control study comprising 59 obese, 61 overweight and 79 lean
individuals [6]. Moreover, ADRB2 haplotypes were reported to
have a physiological effect on measures of blood pressure [7].
Thus, despite the previous lack of a consistent effect of individual
SNPs in ADRB2, there are several indications that haplotypes and
haplotype combinations may have a physiologically significant
effect, yet the effect of haplotypic pairs is so far unexplored in a
large-scale study sample.
Therefore, we examined the impact of the individual haplotypes
and haplotypic combinations within ADRB2. Five SNPs were
selected using pair wise tagging with an R
2 above 0.8 as they were
required to represent variation within the ADRB2 locus covering a
15 Kbp region which included ADRB2 and two flanking linkage
disequilibrium (LD) blocs according to HapMap (http://www.
hapmap.org). This was followed by analyses of the effect of
haplotypes and haplotype combinations in relation to the
prevalence of obesity and hypertension.
Materials and Methods
Study sample
We studied a Danish population-based study sample involving
of 6,514 middle-aged Danes from the greater Copenhagen area
sampled at Research Centre for Prevention and Health (n=6,514;
3,169 men, 3,345 women) aged 4668 years (mean6SD) and
having a (body mass index) BMI of 26.364.6 kg/m
2 (Clinical-
Trials.gov ID-no:NCT00289237 [8]). Hypertension was defined
as mean systolic blood pressure$140 mm Hg and/or mean
diastolic blood pressure$90 mm Hg and/or current or previous
treatment with antihypertensive drugs. Obesity was defined as
individuals having a BMI above 30 kg/m
2. A lean control
individual was defined as having a BMI less the 25 kg/m
2.
Ethics statements
Informed written consent was obtained from all subjects before
participation. The study was approved by the Ethical Committee
of Copenhagen County and was in accordance with the principles
of the Helsinki Declaration.
Anthropometrics and physiological measures
Height and weight were measured in light indoor clothes and
without shoes, and BMI was calculated as weight (kg)/height (m)
2.
Waist circumference was measured at the umbilical level to the
nearest 0.5 cm with the subjects standing using a non-extendable
linen tape measure according to WHO recommendation. The
remaining measures were performed as previously described [9].
Genotyping
rs1042713, rs1042714, rs1800888, rs1042718 and rs1042719
were selected for analysis of the ADRB2 locus using pair wise
tagging with an R
2 above 0.8. Genotyping was performed using
Taqman allelic discrimination (KBioscience, Hoddesdon, UK)
with a genotyping success rate above 97% for all five variants and
only one genotyping error was observed out of a total of 1,726
duplicate samples. All genotype groups obeyed Hardy-Weinberg
equilibrium in the population-based sample of Danes (p.0.2).
Statistical analysis
LD-structure was generated using HaploView 4.1. Fisher’s
exact test was applied to analyse differences in minor allele
frequency as well as genotype distribution of the individual
genotypes. Logistic regression assuming an additive model was
performed to evaluate the difference in genotype distribution
adjusted for sex and age in relation to obesity and hypertensive
status. Multiple linear regression analysis was used to analyse the
effect of individual genotypes on quantitative traits. Haplotype
frequencies were estimated using the expectation-maximization
(EM) algorithm and association was evaluated by global and
haplotype-specific score statistics [10]. The global p-value is an
estimate of the overall effect of haplotypes in the statistical model
and the specific p-value is an estimate of the effect of a specific
haplotype compared to the effect of the remaining haplotypes.
Haplotypes with a frequency below 0.5% were excluded. The
program PHASE version 2.1.1 was used to estimate the
combinations of haplotypes. PHASE is a program using a
Bayesian statistical method for reconstructing haplotypes from
population genotype data developed by Stephens and colleagues
[11,12]. General linear models with adjustment for sex and age
was used to test a reference haplotype combination against the
remaining haplotype combinations (in a pair-wise manner) for
differences in the frequency of obesity and hypertension and traits
related to these conditions and a specific p-value for each
comparison was calculated. The reference was set as the haplotype
combination (4,4). This was chosen as the reference based on the
decreased expression previously seen for the haplotype corre-
sponding to haplotype number 4 in the present study [4]. F-test
(for continuous traits) and Chi-squared (for binary traits) were used
to calculate the global p-value representing the fit to the model
added by haplotype combinations compared to a model including
only sex, age and BMI. Statistical analyses rely on traits being
normally distributed which after evaluation of quantile-quantile
plots were found. Patients with known diabetes (n=108) were
excluded from all quantitative trait analyses and patients receiving
anti-hypertensive treatment (n=403) were excluded from quanti-
tative trait analyses of blood pressure. A statistical power
calculation was performed assuming haplotype frequencies of
39% versus 27% as observed in a previous report [6], a
significance level of 95%, and a sample size of 1,000. All analyses
were performed using RGui version 2.7. A p-value of less than 0.05
was considered to be significant.
Results
The five ADRB2 variants which were genotyped were all located
within the coding region and their allele frequencies were: 38% for
rs1042713; 45% for rs1042714; 1.5% for rs1800888; 15% for
rs1042718 and 28% for rs1042719. The LD-structure for the SNPs
was evaluated and D’ was above 0.8 except for the two variations
located furthest apart (Figure S1). R
2 was below 0.8 for all analyses
(Figure S1). Only variants located within the same LD-block were
included in the haplotypes. Thus, haplotypes were constructed from
rs1042713, rs1042714, rs1800888, and rs1042718. These haplo-
types were examined for association with obesity (Table 1) however;
both specific and global effects were insignificant. Nor was any
association of the haplotypes observed with BMI, waist circumfer-
ence, or body weight (data not shown).
Due to the diploid nature of the human genome the haplotype
combination of each participant was assessed. A total of 21
haplotype combinations were present. Five combinations had a
frequency above 5% and these were selected for further analysis.
These combinations were examined in a case-control study
comparing pair-wise the frequencies of obese versus lean individuals
for each combination against a reference combination (Figure 1A).
This analysis did not detect any effect of the haplotype pairs, a
finding which was supported by a global analysis (p=0.9). When
pair-wise comparisons of BMI, waist circumference and waist/hip
ratio were performed, these combined haplotypes only revealed a
nominal difference in waist-to-hip ratio between the reference and
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ratio (p=0.02; Table 2).
The haplotypes and haplotype combinations were also examined
for association with hypertension. Haplotype analyses yielded the
same lack of association with hypertension and blood pressure
(Table 1). Also, haplotype combinations failed to significantly
associate with hypertension (Figure 1B). However, a nominal
significant difference inmeasuresofsystolic blood pressureaswell as
mean arterial blood pressure was observed between the reference
combination and haplotype combination 2,4 with the latter having
an increased blood pressure (Table 2).
Interactions between sex and the individual variants as well as
haplotype pairs were examined (data not shown). Minor
interaction was seen between rs1042719 and sex for measures of
blood pressure; however, when performing sex stratified analyses
for this variant no significant associations was found (data not
shown). In contrast, we did not observe any interaction between
sex and the effect of the haplotype pairs.
All of the above analyses were also performed after removal of
the rare rs1800888, yet no robust associations were found except
for an association with waist-to-hip ratio of a haplotype pair
corresponding to 6,2 excluding rs1800888 (data not shown).
Despite the overall aim to evaluate the effect of haplotype
combinations, the effect of individual genotypes was examined, yet
no effect on either obesity or hypertension was observed for
rs1800888, rs1042718, and rs1042719 (Table S1). The same lack
of association was observed for the quantitative traits study (Table
S2), except for a nominal association with increased waist-to-hip
ratio for rs1042718 (p=0.03).
Discussion
No consistent association with body weight or blood pressure
regulation was found for the individual ADRB2 locus haplotypes.
Neither did analyses of ADRB2 haplotype combinations indicate
any physiological impact on weight status except from the nominal
difference in waist-to-hip ratio between the reference and the
haplotype combination 6,2.
If the haplotype previously showing a decreased expression
(haplotype number 4) had a physiologically impact on weight
regulation, we would expect this haplotype to be associated with
increased BMI, waist circumference or waist-hip ratio or an
increased proportion of obese individuals due to a reduced
lipolysis. Or it could have been expected that the haplotype
Figure 1. Case-control study comparing the frequency of obese
and hypertensive individuals among the ADRB2 haplotype
pairs, respectively. A: The proportion of obese out of the combined
number of individuals in the lean group (BMI,25 kg/m
2) and the obese
(BMI.30 kg/m
2) group (n=3,189). B: The proportion of hypertensive
individuals out of the combined number of individuals in the
normotensive group and the hypertensive group (n=5,211).
doi:10.1371/journal.pone.0007206.g001
Table 1. ADRB2 haplotype analysis comparing obesity and hypertension status among 5,838 and 5,584 individuals from the
Inter99 study sample, respectively.
Number
corresponding
to (2).
rs1042713
(Gly16Arg)
rs1042714
(Gln27Glu)
rs1800888
(Thr164Ile)
rs1042718 (AA175
Synonymous) Frequency (%)
Obesity
Specific p-value
Hypertension
Specific p-value
2 G G C C 44 0.5 0.6
5 G C C C 3 0.7 0.9
7 G C T A 2 0.8 1.0
6 G C C A 13 0.9 0.1
4 A C C C 38 0.5 0.1
Global p-value 1.0 0.4
Haplotype frequencies were estimated using the expectation-maximization (EM) algorithm and association was evaluated by global and haplotype-specific score
statistics (Schaid et al.2002). The global p-value is an estimate for the overall effect of haplotypes in the statistical model and the specific p-value is an estimate of the
effect of a specific haplotype compared to the effect of the remaining haplotypes combined. Obesity status was examined as individuals having a BMI below 25 kg/m
2
vs. individuals having a BMI above 30 kg/m
2. Hypertension status was examined as mean systolic blood pressure$140 mm Hg and/or mean diastolic blood
pressure$90 mm Hg and/or current or previous treatment with antihypertensive drugs vs. normotensive individuals.
doi:10.1371/journal.pone.0007206.t001
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(4,4) lead to a higher BMI due to a reduced agonist response and
thus lower lipolysis. Yet, this is not the case.
Examination of the influence of haplotype combinations on
measures of blood pressure showed a nominal effect of the
haplotype combination 2,4 compared to haplotype pair 4,4. This
combination is composed of the haplotypes previously showing the
highest (2) and the lowest expression (4) of mRNA and protein in
vitro, thus there is no apparent link between expression and the
physiological response observed. Also, no clear relation was seen
between the haplotype combination (2,4) associating with
increased blood pressure in the present study - most likely caused
by vessel contraction - and the haplotype combination (6,6)
previous associating with increased noradrenalin sensitivity
measured in fat cells as maximum effect on lipolysis [5].
A statistical power calculation was performed based on the
previously reported effect of ADRB2 haplotypes on obesity (OR:
0.58;CI:0.34–0.96)[6].Inour studywehavea statisticalpowerof1
to detect an equivalent association. If the haplotype pairs showing
nominal effects on waist-to-hip ratio (4,4 and 6,2) and systolic blood
pressure (4,4 and 2,4) are used for obesity and hypertension case-
control studies, we can based on the OR confidence intervals
estimate that it is unlikely in the present study population to find
effect sizes on obesity above 1.4 and above 1.3 on hypertension.
Marker-by-marker analyses of rs1800888, rs1042718 and
rs1042719 of ADRB2 in the present study and the previous
published analyses of rs1042713 and rs1042719 [4] showed
nominally significant association with waist-to-hip ratio and systolic
blood pressure in line with the results seen for haplotype pairs.
In summary, based on the findings of the present population
based study in 6,514 adult Danes there is no evidence of functional
haplotypes in the ADRB2 locus with significant impact on body
fatness or blood pressure regulation.
Supporting Information
Table S1 Case-control studies examining the individual effects
of variants in ADRB2 on obesity and hypertension among 6,514
individuals from the Inter99 study sample.
Found at: doi:10.1371/journal.pone.0007206.s001 (0.08 MB
RTF)
Table S2 Quantitative trait analyses associations between 3
common ADRB2 variants and measures related to obesity and
hypertension among 6,039 and 5,638 Danes from the inter99
study sample, respectively.
Found at: doi:10.1371/journal.pone.0007206.s002 (0.08 MB
RTF)
Figure S1 Pair-wise LD plot calculated for the present study
population of 5,730 Danes for the five ADRB2 variants estimated
using D’ (A) and R
2 (B).
Found at: doi:10.1371/journal.pone.0007206.s003 (7.65 MB TIF)
Table 2. Comparison between ADRB2 haplotype combinations and body composition and blood pressure among 4,885 and 4,566
Danish individuals, respectively.
Haplotype combination 4,4 2,4 2,2 6,2 6,4
BMI (kg/m2) 26.164.8 26.364.7 26.264.3 26.064.4 26.264.9
Specific p-value - 0.3 0.6 0.9 0.9
Global p-value 0.8
Waist (cm) 86.0613.4 86.6613.3 86.3612.9 86.5613.3 86.4613.2
Specific p-value - 0.3 0.3 0.5 0.7
Global p-value 0.8
Waist/hip ratio 0.8560.09 0.8560.08 0.8560.09 0.8660.09 0.8660.09
Specific p-value - 0.7 0.4 0.02 0.7
Estimate of effect 0.008
Global p-value 0.1
Systolic blood pressure (mm Hg) 128.1616.0 129.7617.0 128.9616.5 129.6616.8 129.0617.3
Specific p-value - 0.04 0.2 0.1 0.5
Estimate of effect 1.40
Global p-value 0.3
Diastolic blood pressure (mm Hg) 81.2610.7 82.1611.1 81.6610.9 82.0611.0 81.5611.3
Specific p-value - 0.09 0.3 0.2 0.7
Estimate of effect
Global p-value 0.4
MABP 96.8611.6 98.0612.3 97.4611.9 97.9612.2 97.4612.6
Specific p-value - 0.05 0.2 0.1 0.6
Estimate of effect 0.99
Global p-value 0.3
Data is mean6SD. P-values were corrected for age and sex. MABP (mean arterial blood pressure) is calculated as [(26diastolic blood pressure)+systolic blood pressure]
divided by 3. The specific p-value is calculated based on a pair-wise comparison of the haplotype combination with the reference haplotype combination (4,4) using a
multiple linear regression and the global p-value has been calculated using an ANOVA. Patients with known diabetes were excluded from all of the above analyses and
patients receiving anti-hypertensive treatment were excluded from blood pressure trait analyses.
doi:10.1371/journal.pone.0007206.t002
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